{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:40:10Z","timestamp":1771501210405,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"\u201cMajor New Drug Discovery\u201d of China","award":["2017ZX09201-002"],"award-info":[{"award-number":["2017ZX09201-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s13346-017-0456-6","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T13:34:44Z","timestamp":1511789684000},"page":"252-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Influence of polymeric carrier on the disposition and retention of 20(R)-ginsenoside-rg3-loaded swellable microparticles in the lung"],"prefix":"10.1007","volume":"8","author":[{"given":"Xiuhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-6559","authenticated-orcid":false,"given":"Shirui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"issue":"2","key":"456_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. Ca-Cancer J Clin. 2015;65(2):87\u2013108. \nhttps:\/\/doi.org\/10.3322\/caac.21262\n\n.","journal-title":"Ca-Cancer J Clin"},{"issue":"1","key":"456_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. Ca-Cancer J Clin. 2015;65(1):5\u201329. \nhttps:\/\/doi.org\/10.3322\/caac.21254\n\n.","journal-title":"Ca-Cancer J Clin"},{"issue":"5","key":"456_CR3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386. \nhttps:\/\/doi.org\/10.1002\/ijc.29210\n\n.","journal-title":"Int J Cancer"},{"issue":"17","key":"456_CR4","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1016\/j.bmc.2005.04.084","volume":"13","author":"S Jaracz","year":"2005","unstructured":"Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem. 2005;13(17):5043\u201354. \nhttps:\/\/doi.org\/10.1016\/j.bmc.2005.04.084\n\n.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"456_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cmdc.200700159","volume":"3","author":"F Kratz","year":"2008","unstructured":"Kratz F, M\u00fcller IA, Ryppa C, Warnecke A. Prodrug strategies in anticancer chemotherapy. ChemMedChem. 2008;3(1):20\u201353. \nhttps:\/\/doi.org\/10.1002\/cmdc.200700159\n\n.","journal-title":"ChemMedChem"},{"issue":"6","key":"456_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labiris","year":"2003","unstructured":"Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56(6):588\u201399. \nhttps:\/\/doi.org\/10.1046\/j.1365-2125.2003.01892.x\n\n.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"456_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.drudis.2014.09.020","volume":"20","author":"Z Liang","year":"2015","unstructured":"Liang Z, Ni R, Zhou J, Mao S. Recent advances in controlled pulmonary drug delivery. Drug Discov Today. 2015;20(3):380\u20139. \nhttps:\/\/doi.org\/10.1016\/j.drudis.2014.09.020\n\n.","journal-title":"Drug Discov Today"},{"issue":"5320","key":"456_CR8","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","volume":"276","author":"DA Edwards","year":"1997","unstructured":"Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, et al. Large porous particles for pulmonary drug delivery. Science (New York, N.Y.). 1997;276(5320):1868\u201371. \nhttps:\/\/doi.org\/10.1126\/science.276.5320.1868\n\n.","journal-title":"Science (New York, N.Y.)"},{"key":"456_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejps.2016.12.013","volume":"99","author":"R Ni","year":"2017","unstructured":"Ni R, Zhao J, Liu Q, Liang Z, Muenster U, Mao S. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery. Eur J Pharm Sci. 2017;99:137\u201346. \nhttps:\/\/doi.org\/10.1016\/j.ejps.2016.12.013\n\n.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"456_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ajps.2015.08.009","volume":"10","author":"W-H Lee","year":"2015","unstructured":"Lee W-H, Loo CY, Traini D, Young PM. Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges. Asian J Pharm Sci. 2015;10(6):481\u20139. \nhttps:\/\/doi.org\/10.1016\/j.ajps.2015.08.009\n\n.","journal-title":"Asian J Pharm Sci"},{"key":"456_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2014.03.012","volume":"183","author":"LM Kaminskas","year":"2014","unstructured":"Kaminskas LM, McLeod VM, Ryan GM, Kelly BD, Haynes JM, Williamson M, et al. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. J Control Release. 2014;183:18\u201326. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2014.03.012\n\n.","journal-title":"J Control Release"},{"key":"456_CR12","doi-asserted-by":"publisher","unstructured":"Zhong Q. Co-spray dried mannitol\/poly(amidoamine)-doxorubicin dry-powder inhaler formulations for lung adenocarcinoma: morphology, in vitro evaluation, and aerodynamic performance. AAPS PharmSciTech. 2017; \nhttps:\/\/doi.org\/10.1208\/s12249-017-0859-1\n\n.","DOI":"10.1208\/s12249-017-0859-1"},{"issue":"7","key":"456_CR13","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1021\/acs.molpharmaceut.6b00126","volume":"13","author":"Q Zhong","year":"2016","unstructured":"Zhong Q, Bielski ER, Rodrigues LS, Brown MR, Reineke JJ, da Rocha SRP. Conjugation to poly(amidoamine) dendrimers and pulmonary delivery reduce cardiac accumulation and enhance antitumor activity of doxorubicin in lung metastasis. Mol Pharm. 2016;13(7):2363\u201375. \nhttps:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00126\n\n.","journal-title":"Mol Pharm"},{"issue":"5","key":"456_CR14","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/jps.22003","volume":"99","author":"IM El-Sherbiny","year":"2010","unstructured":"El-Sherbiny IM, McGill S, Smyth HDC. Swellable microparticles as carriers for sustained pulmonary drug delivery. J Pharm Sci. 2010;99(5):2343\u201356. \nhttps:\/\/doi.org\/10.1002\/jps.22003\n\n.","journal-title":"J Pharm Sci"},{"issue":"2","key":"456_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1021\/mp200351y","volume":"9","author":"IM El-Sherbiny","year":"2012","unstructured":"El-Sherbiny IM, Smyth HDC. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharm. 2012;9(2):269\u201380. \nhttps:\/\/doi.org\/10.1021\/mp200351y\n\n.","journal-title":"Mol Pharm"},{"issue":"2","key":"456_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1517\/17425247.2.2.205","volume":"2","author":"K Yoncheva","year":"2005","unstructured":"Yoncheva K, G\u00f3mez S, Campanero MA, Gamazo C, Irache JM. Bioadhesive properties of pegylated nanoparticles. Expert Opin Drug Deliv. 2005;2(2):205\u201318. \nhttps:\/\/doi.org\/10.1517\/17425247.2.2.205\n\n.","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"456_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","volume":"81","author":"A Bernkop-Schnuerch","year":"2012","unstructured":"Bernkop-Schnuerch A, Duennhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81(3):463\u20139. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2012.04.007\n\n.","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"456_CR18","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1021\/bc300248t","volume":"23","author":"SR Datir","year":"2012","unstructured":"Datir SR, Das M, Singh RP, Jain S. Hyaluronate tethered, \u201csmart\u201d multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem. 2012;23(11):2201\u201313. \nhttps:\/\/doi.org\/10.1021\/bc300248t\n\n.","journal-title":"Bioconjug Chem"},{"issue":"4","key":"456_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/mp800024g","volume":"5","author":"VM Platt","year":"2008","unstructured":"Platt VM, Szoka FC Jr. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm. 2008;5(4):474\u201386. \nhttps:\/\/doi.org\/10.1021\/mp800024g\n\n.","journal-title":"Mol Pharm"},{"issue":"2","key":"456_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10611860701794296","volume":"16","author":"AK Yadav","year":"2008","unstructured":"Yadav AK, Mishra P, Agrawal GP. An insight on hyaluronic acid in drug targeting and drug delivery. J Drug Target. 2008;16(2):91\u2013107. \nhttps:\/\/doi.org\/10.1080\/10611860701794296\n\n.","journal-title":"J Drug Target"},{"issue":"1","key":"456_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11655-007-9002-6","volume":"14","author":"P Lu","year":"2008","unstructured":"Lu P, Su W, Miao Zh, Niu Hr, Liu J, Hua Ql. Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chin J Integr Med. 2008;14(1):33\u20136. \nhttps:\/\/doi.org\/10.1007\/s11655-007-9002-6\n\n.","journal-title":"Chin J Integr Med"},{"issue":"4","key":"456_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bcp.2006.04.034","volume":"72","author":"PYK Yue","year":"2006","unstructured":"Yue PYK, Wong DYL, Wu PK, Leung PY, Mak NK, Yeung HW, et al. The angiosuppressive effects of 20(R)-ginsenoside Rg(3). Biochem Pharmacol. 2006;72(4):437\u201345. \nhttps:\/\/doi.org\/10.1016\/j.bcp.2006.04.034\n\n.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"456_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1349-7006.1996.tb00230.x","volume":"87","author":"K Shinkai","year":"1996","unstructured":"Shinkai K, Akedo H, Mukai M, Imamura F, Isoai A, Kobayashi M, et al. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res: Gann. 1996;87(4):357\u201362. \nhttps:\/\/doi.org\/10.1111\/j.1349-7006.1996.tb00230.x\n\n.","journal-title":"Jpn J Cancer Res: Gann"},{"issue":"1","key":"456_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0006-2952(02)01446-6","volume":"65","author":"SW Kim","year":"2003","unstructured":"Kim SW, Kwon Hy, Chi DW, Shim JH, Park JD, Lee YH, et al. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol. 2003;65(1):75\u201382. \nhttps:\/\/doi.org\/10.1016\/S0006-2952(02)01446-6\n\n.","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"456_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijpharm.2004.05.019","volume":"281","author":"SR Mao","year":"2004","unstructured":"Mao SR, et al. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm. 2004;281(1\u20132):45\u201354. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2004.05.019\n\n.","journal-title":"Int J Pharm"},{"issue":"3","key":"456_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/13816128113199990401","volume":"20","author":"X Zhang","year":"2014","unstructured":"Zhang X, Li LC, Mao S. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies. Curr Pharm Des. 2014;20(3):388\u2013407. \nhttps:\/\/doi.org\/10.2174\/13816128113199990401\n\n.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"456_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0378-5173(99)00387-7","volume":"194","author":"A Bernkop-Schnurch","year":"2000","unstructured":"Bernkop-Schnurch A, Steininger S. Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm. 2000;194(2):239\u201347. \nhttps:\/\/doi.org\/10.1016\/S0378-5173(99)00387-7\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"456_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2008.12.011","volume":"135","author":"F Ungaro","year":"2009","unstructured":"Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, et al. Insulin-loaded PLGA\/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release. 2009;135(1):25\u201334. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2008.12.011\n\n.","journal-title":"J Control Release"},{"issue":"3","key":"456_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/089426803769017659","volume":"16","author":"VA Marple","year":"2003","unstructured":"Marple VA, Roberts DL, Romay FJ, Miller NC, Truman KG, van Oort M, et al. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: design. J Aerosol Med-Depos Clearance Eff Lung. 2003;16(3):283\u201399. \nhttps:\/\/doi.org\/10.1089\/089426803769017659\n\n.","journal-title":"J Aerosol Med-Depos Clearance Eff Lung"},{"issue":"2","key":"456_CR30","first-page":"255","volume":"27","author":"JL Mauderly","year":"1977","unstructured":"Mauderly JL. Bronchopulmonary lavage of small laboratory animals. Lab Anim Sci. 1977;27(2):255\u201361.","journal-title":"Lab Anim Sci"},{"issue":"3","key":"456_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1248\/cpb.48.393","volume":"48","author":"PW Heng","year":"2000","unstructured":"Heng PW, Chan LW, Lim LT. Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate. Chem Pharm Bull. 2000;48(3):393\u20138. \nhttps:\/\/doi.org\/10.1248\/cpb.48.393\n\n.","journal-title":"Chem Pharm Bull"},{"key":"456_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2017.01.023","volume":"249","author":"R Ni","year":"2017","unstructured":"Ni R, Muenster U, Zhao J, Zhang L, Becker-Pelster EM, Rosenbruch M, et al. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: in vitro and in vivo characterization. J Control Release. 2017;249:11\u201322. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2017.01.023\n\n.","journal-title":"J Control Release"},{"issue":"8","key":"456_CR33","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1002\/jps.22587","volume":"100","author":"W Sun","year":"2011","unstructured":"Sun W, Mao S, Shi Y, Li LC, Fang L. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci. 2011;100(8):3365\u201373. \nhttps:\/\/doi.org\/10.1002\/jps.22587\n\n.","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"456_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0378-5173(02)00349-6","volume":"245","author":"C Dunbar","year":"2002","unstructured":"Dunbar C, Scheuch G, Sommerer K, DeLong M, Verma A, Batycky R. In vitro and in vivo dose delivery characteristics of large porous particles for inhalation. Int J Pharm. 2002;245(1\u20132):179\u201389. \nhttps:\/\/doi.org\/10.1016\/S0378-5173(02)00349-6\n\n.","journal-title":"Int J Pharm"},{"issue":"7","key":"456_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaerosci.2007.04.005","volume":"38","author":"R Vehring","year":"2007","unstructured":"Vehring R, Foss WR, Lechuga-Ballesteros D. Particle formation in spray drying. J Aerosol Sci. 2007;38(7):728\u201346. \nhttps:\/\/doi.org\/10.1016\/j.jaerosci.2007.04.005\n\n.","journal-title":"J Aerosol Sci"},{"issue":"5","key":"456_CR36","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","volume":"25","author":"R Vehring","year":"2008","unstructured":"Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25(5):999\u20131022. \nhttps:\/\/doi.org\/10.1007\/s11095-007-9475-1\n\n.","journal-title":"Pharm Res"},{"issue":"11","key":"456_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jaerosci.2008.07.003","volume":"39","author":"J Yao","year":"2008","unstructured":"Yao J, Kuang Lim L, Xie J, Hua J, Wang CH. Characterization of electrospraying process for polymeric particle fabrication. J Aerosol Sci. 2008;39(11):987\u20131002. \nhttps:\/\/doi.org\/10.1016\/j.jaerosci.2008.07.003\n\n.","journal-title":"J Aerosol Sci"},{"issue":"1","key":"456_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11095-004-9020-4","volume":"22","author":"NYK Chew","year":"2005","unstructured":"Chew NYK, Tang P, Chan HK, Raper JA. How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharm Res. 2005;22(1):148\u201352. \nhttps:\/\/doi.org\/10.1007\/s11095-004-9020-4\n\n.","journal-title":"Pharm Res"},{"key":"456_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.powtec.2012.02.051","volume":"236","author":"S Adi","year":"2013","unstructured":"Adi S, Adi H, Chan HK, Tong Z, Yang R, Yu A. Effects of mechanical impaction on aerosol performance of particles with different surface roughness. Powder Technol. 2013;236:164\u201370. \nhttps:\/\/doi.org\/10.1016\/j.powtec.2012.02.051\n\n.","journal-title":"Powder Technol"},{"issue":"7","key":"456_CR40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1289\/ehp.7339","volume":"113","author":"G Oberdorster","year":"2005","unstructured":"Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823\u201339. \nhttps:\/\/doi.org\/10.1289\/ehp.7339\n\n.","journal-title":"Environ Health Perspect"},{"issue":"2","key":"456_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jconrel.2004.01.027","volume":"96","author":"C Bosquillon","year":"2004","unstructured":"Bosquillon C, Prat W, Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Control Release. 2004;96(2):233\u201344. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2004.01.027\n\n.","journal-title":"J Control Release"},{"issue":"8","key":"456_CR42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1023\/A:1018901302450","volume":"11","author":"L Illum","year":"1994","unstructured":"Illum L, Farraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res. 1994;11(8):1186\u20139. \nhttps:\/\/doi.org\/10.1023\/A:1018901302450\n\n.","journal-title":"Pharm Res"},{"issue":"3","key":"456_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0168-3659(88)90021-1","volume":"5","author":"L Sau-Hung Spence","year":"1987","unstructured":"Sau-Hung Spence L, Robinson JR. The contribution of anionic polymer structural features to mucoadhesion. J Control Release. 1987;5(3):223\u201331. \nhttps:\/\/doi.org\/10.1016\/0168-3659(88)90021-1\n\n.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-017-0456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T11:45:33Z","timestamp":1515152733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-017-0456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s13346-017-0456-6","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}